Insider Sales Outpace Purchases, Led by Braze and Dutch Bros
Recent insider filings showed more selling than buying, led by Braze’s CTO selling $13.2 million in shares and Dutch Bros insiders selling a combined $12.81 million. Rapport Therapeutics stood out with four directors buying more than $1.4 million in stock. A reported $2.01 billion sale by InnSuites Hospitality Trust’s CEO was treated as anomalous.
The Oct. 22, 2026 evening filing review covered roughly the prior 20 hours and found 49 sales worth about $55.5 million versus 16 purchases totaling roughly $9.7 million, excluding an anomalous reported $2.01 billion InnSuites Hospitality Trust CEO sale. Braze CTO Jonathan Hyman’s 295,000-share, $13.2 million disposal was the largest single highlighted sale.
Dutch Bros showed a cluster: Executive Chairman Travis Boersma sold $6.4 million, while two 10% owners, DM Individual Aggregator and DM Trust Aggregator, sold $2.23 million and $4.18 million. Rapport Therapeutics was the notable buyer, with four directors purchasing more than $1.4 million.
The heavy insider selling could affect ordinary investors and employees by reinforcing caution about near-term prospects at the named companies, while the Rapport purchases may offer a counterpoint. Because filings are backward-looking and can reflect diversification or compensation, they may influence sentiment more than fundamentals; retail savers and fund holders could see volatility, and employees with stock-based pay may feel the signal most directly.